Product Recalls and Safety

The U.S. Food and Drug Administration has posted a nationwide Class II recall of nearly 90,000 bottles of Children’s Ibuprofen Oral Suspension after the manufacturer, Strides Pharma, received complaints of a "gel‑like mass and black particles" in some bottles. The liquid ibuprofen, a berry‑flavored pain and fever reducer for children ages 2 to 11, is manufactured in India by Strides for Taro Pharmaceuticals and was distributed across the United States. Class II status means exposure could cause temporary or medically reversible adverse health consequences, according to FDA criteria, though the agency has not reported any confirmed injuries tied to the contamination so far. Parents are being urged to check labels for the recalled product, identified under FDA recall number D‑0390‑2026, and to stop using any affected bottles pending further guidance from the company or regulators. The case underscores recurring quality‑control concerns around some foreign‑manufactured generics and over‑the‑counter medicines used widely by U.S. families, especially for children.